Caribou Biosciences, Inc. Share Price
CRBUCaribou Biosciences, Inc. Stock Performance
Open $1.65 | Prev. Close $1.66 | Circuit Range N/A |
Day Range $1.59 - $1.67 | Year Range $1.39 - $3.54 | Volume 40,995 |
Average Traded $1.62 |
Caribou Biosciences, Inc. Share Price Chart
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $1.65 | $1.61 | +0.00% |
20-Jul-26 | $1.65 | $1.61 | -2.42% |
17-Jul-26 | $1.64 | $1.65 | -1.20% |
16-Jul-26 | $1.71 | $1.67 | -3.47% |
15-Jul-26 | $1.76 | $1.73 | -1.14% |
14-Jul-26 | $1.81 | $1.75 | -3.31% |
13-Jul-26 | $1.86 | $1.81 | -5.73% |
FAQs on Caribou Biosciences, Inc. Share Price
Can I buy Caribou Biosciences, Inc. shares in India?
What is the share price of Caribou Biosciences, Inc.?
What is the 5 year returns of Caribou Biosciences, Inc.?
What are the high & low stock price of Caribou Biosciences, Inc. today?
What is the 52-week high and low of Caribou Biosciences, Inc. stock?